ArticleCancers2025

Effectiveness of First-Line Treatment with Anaplastic Lymphoma Kinase and ROS1 Protoncogene Inhibitors in Non-Small Cell Lung Cancer Patients-Real-World Evidence of Two Polish Cancer Centers.

Michał Gil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.